These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1888251)

  • 41. Tamoxifen in breast cancer: symptom reporting.
    Arnold BJ; Cumming CE; Lees AW; Handman MD; Cumming DC; Urion C
    Breast J; 2001; 7(2):97-100. PubMed ID: 11328315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Traditional Korean medicine treatment for tamoxifen associated adverse events of breast cancer patient: A CARE - Compliant case report.
    Seo J; Lee D; Jo HG
    Complement Ther Clin Pract; 2021 May; 43():101378. PubMed ID: 33845285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complexions of compliance.
    Penson RT
    Menopause; 2013 Jan; 20(1):3-4. PubMed ID: 23266837
    [No Abstract]   [Full Text] [Related]  

  • 44. The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot study.
    Watkins SM
    Br J Cancer; 1988 Mar; 57(3):320-1. PubMed ID: 3355772
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of long term tamoxifen treatment on bone turnover in women with breast cancer.
    Wright CD; Mansell RE; Gazet JC; Compston JE
    BMJ; 1993 Feb; 306(6875):429-30. PubMed ID: 8461725
    [No Abstract]   [Full Text] [Related]  

  • 46. My best case: homeopathic management of adverse effects of tamoxifen.
    Bagot JL; Delègue C
    Wien Med Wochenschr; 2020 Jun; 170(9-10):224-229. PubMed ID: 30539320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian cancer and long-term tamoxifen in premenopausal women.
    Spicer DV; Pike MC; Henderson BE
    Lancet; 1991 Jun; 337(8754):1414. PubMed ID: 1674785
    [No Abstract]   [Full Text] [Related]  

  • 48. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity: a prospective study of 63 patients.
    Flach AJ
    Surv Ophthalmol; 1994; 38(4):392-3. PubMed ID: 8160114
    [No Abstract]   [Full Text] [Related]  

  • 49. Mood disorder in women with early breast cancer taking tamoxifen, an estradiol receptor antagonist. An expected or unexpected effect?
    Shariff S; Cumming CE; Lees A; Handman M; Cumming DC
    Ann N Y Acad Sci; 1995 Jun; 761():365-8. PubMed ID: 7625737
    [No Abstract]   [Full Text] [Related]  

  • 50. Meeting report: long-term antihormonal therapy for breast cancer.
    Costa A; Jordan VC
    Eur J Cancer; 1991; 27(11):1479-81. PubMed ID: 1835865
    [No Abstract]   [Full Text] [Related]  

  • 51. Tamoxifen in early breast cancer.
    Greenspan EM
    Lancet; 1983 Mar; 1(8325):655. PubMed ID: 6131338
    [No Abstract]   [Full Text] [Related]  

  • 52. Fatal neutropenia associated with long-term tamoxifen therapy.
    Miké V; Currie VE; Gee TS
    Lancet; 1994 Aug; 344(8921):541-2. PubMed ID: 7914632
    [No Abstract]   [Full Text] [Related]  

  • 53. Tamoxifen as a potential preventive agent in healthy postmenopausal women.
    Prentice RL
    J Natl Cancer Inst; 1990 Aug; 82(16):1310-1. PubMed ID: 2380989
    [No Abstract]   [Full Text] [Related]  

  • 54. Precautions for Patients Taking Tamoxifen.
    Heery M; Corbett P; Zelkowitz R
    J Adv Pract Oncol; 2018; 9(1):78-83. PubMed ID: 30564470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction in vasomotor symptoms from tamoxifen over time.
    Love RR; Feyzi JM
    J Natl Cancer Inst; 1993 Apr; 85(8):673-4. PubMed ID: 8468727
    [No Abstract]   [Full Text] [Related]  

  • 56. Menopause symptoms can fool women into quitting cancer drugs.
    Nurs Stand; 2017 Jul; 31(47):17. PubMed ID: 28721759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Use of Tamoxifen as a Potential Treatment for Bipolar Disorder.
    Bagdadi N; N Azab A; Shvartsur R
    Psychiatry Clin Psychopharmacol; 2021 Sep; 31(3):344-352. PubMed ID: 38765942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation.
    Hao Z; Xu J; Zhao H; Zhou W; Liu Z; He S; Yin X; Zhang B; Wang Z; Zhou X
    BMC Pharmacol Toxicol; 2022 May; 23(1):33. PubMed ID: 35642027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer.
    Maharjan CK; Mo J; Wang L; Kim MC; Wang S; Borcherding N; Vikas P; Zhang W
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review.
    Chan CWH; Law BMH; Ng MSN; Wong CCY; Wong CWY; Quinley M; Orgusyan JM; Chow KM; Waye MMY
    BMC Cancer; 2021 May; 21(1):570. PubMed ID: 34006247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.